For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

F or the past 60 years, a committee of independent experts has advised the federal government on vaccine policy, providing ...

The S&P 500 added 0.9% on Monday, June 16, as investors absorbed the possibility of cooling geopolitical tensions and looked ...

A federal judge in Massachusetts ruled on Monday that directives from the Trump administration that led to the cancellations ...